Cynthia Seidel-Dugan
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Cynthia Seidel-Dugan worked as the Chief Scientific Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, she was the Vice President-Biology at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Currently, she is the Chief Scientific Officer at Werewolf Therapeutics, Inc. from 2019 to 2024.
Dr. Seidel-Dugan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The College of William & Mary.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/01/2024 | 164 888 ( 0.39% ) | 1 M $ | 31/03/2024 |
Precedenti posizioni note di Cynthia Seidel-Dugan
| Società | Posizione | Fine |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/03/2024 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2018 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/02/2014 |
Formazione di Cynthia Seidel-Dugan
| University of Pennsylvania | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Cynthia Seidel-Dugan
